1.
Pastaki Khoshbin A, Darbeheshti F, Doosti-Irani A, Keshavarz-Fathi M, Mansournia MA. Efficacy and Safety of Small-Molecule Human Epidermal Growth Factor Receptor 2 (HER2)-Targeting Tyrosine Kinase Inhibitor-Containing Regimens for Metastatic HER2-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis of Randomized Clinical. Immunol Genet J. 2025;8.